VKORC1 rs7294: What Your Genotype Means for Warfarin Dosing
The rs7294 variant is a single nucleotide polymorphism located in the VKORC1 gene, which plays a critical role in how the body processes vitamin K. Research suggests this variant may influence the maintenance dose of warfarin, a common anticoagulant medication, by affecting gene regulation.
What each genotype means
Lower warfarin dose requirement
Research indicates that individuals with the CC genotype may require a lower maintenance dose of warfarin compared to those carrying the T allele. This variant is located in the VKORC1 gene, which is critical for vitamin K metabolism and warfarin response. Please discuss your specific dosing needs with your clinician or pharmacist, as clinical factors like age and weight also significantly influence required doses.
This genotype is common in many populations, though its frequency varies significantly by ancestry, being particularly prevalent in some East Asian cohorts.
Intermediate warfarin dose requirement
Carriers of the CT genotype often show an intermediate response to warfarin compared to the CC and TT genotypes. Evidence regarding the exact dose adjustment for this genotype can be conflicting across different studies. You should consult your healthcare provider to determine the most appropriate warfarin dosing strategy based on your clinical profile.
This heterozygous genotype is found across diverse global populations, with frequencies that depend heavily on the specific ancestral background of the individual.
Higher warfarin dose requirement
Studies suggest that individuals with the TT genotype may require a higher maintenance dose of warfarin to achieve the desired therapeutic effect compared to those with the CC genotype. This association reflects the role of VKORC1 in regulating the body's sensitivity to anticoagulants. Always coordinate with your medical team to ensure your warfarin dosage is safely managed and monitored.
The TT genotype is observed in various populations, though it is less common than the CC genotype in many East Asian groups.
Understanding the rs7294 Variant
The rs7294 variant is a specific genetic change located in the 3' untranslated region (3'UTR) of the VKORC1 gene. In genetics, a single nucleotide polymorphism (SNP) like rs7294 represents a variation at a single position in the DNA sequence. Because this variant sits in the 3'UTR—a region involved in regulating how much protein is produced from a gene—researchers have investigated whether it acts as a 'mirSNP.' This means it may alter how microRNAs bind to the gene, potentially changing the levels of the VKORC1 enzyme available in the liver. While some studies have linked this variant to differences in warfarin dose requirements, its influence is often studied alongside other, more prominent variants in the same gene, such as rs9923231.
The Role of the VKORC1 Gene
The VKORC1 gene provides the instructions for creating the vitamin K epoxide reductase enzyme. This enzyme is essential for the vitamin K cycle, a process that activates clotting factors in the blood. Warfarin works by inhibiting this enzyme, effectively slowing down the body's ability to produce these clotting factors and thereby thinning the blood. Because VKORC1 is the direct target of warfarin, any genetic variation that changes the amount or function of this enzyme can significantly impact how sensitive a person is to the drug. If an individual has a genetic profile that results in lower enzyme activity, they may require a lower dose of warfarin to achieve the same therapeutic effect, whereas higher activity may necessitate a higher dose.
Research and Clinical Evidence
The evidence linking rs7294 to warfarin dosing is considered moderate and often context-dependent. Multiple studies have observed that carriers of different alleles at this locus show variations in their required maintenance dose of warfarin. For instance, some research indicates that certain genotypes are associated with higher dose requirements, while others may be linked to lower plasma concentrations of the drug. However, the strength of this association can vary significantly between different ancestral populations and may be influenced by linkage disequilibrium—a phenomenon where rs7294 is inherited alongside other nearby genetic variants. Because of these complexities, clinical guidelines often prioritize other well-established markers, and the independent predictive power of rs7294 is still a subject of ongoing scientific investigation.
Population Frequency
The frequency of the rs7294 alleles varies across different global populations. Genetic studies indicate that the distribution of this variant is not uniform, which contributes to the observed differences in how various ethnic groups respond to warfarin therapy. Because allele frequencies are highly variable, researchers emphasize that dosing algorithms must be tailored to the specific genetic background of the patient population being treated.
What This Information Means for You
If you have received information about your rs7294 genotype, it is important to understand that this is only one piece of a much larger puzzle. Warfarin dosing is complex and depends on many factors, including age, body weight, diet, other medications, and multiple genetic markers beyond just this single SNP. You should never use genetic information to adjust your medication dosage on your own. If you are taking warfarin or are prescribed it in the future, discuss your genetic results with your healthcare provider or a clinical pharmacist. They are the only ones qualified to interpret these results in the context of your overall health and to determine if a dose adjustment is appropriate for your specific clinical needs.
How common is this variant?
The frequency of the rs7294 variant is highly variable across different ancestral populations, which is a key factor in why its impact on warfarin dosing can differ by ethnicity.
Frequently asked questions
Does having a specific rs7294 genotype mean I am resistant to warfarin?
Not necessarily. While rs7294 is studied for its potential impact on warfarin dosing, it is only one of many factors. Resistance or sensitivity is determined by a combination of genetics, clinical factors, and lifestyle, and should be evaluated by your doctor.
Should I change my warfarin dose based on my rs7294 results?
No. You should never change your medication dosage based on genetic test results without consulting your healthcare provider. Only a clinician can safely determine if a dose adjustment is necessary based on your full medical profile.
Is rs7294 the most important gene for warfarin dosing?
No. While VKORC1 is a major gene for warfarin response, other genes like CYP2C9 are also critical. Most clinical dosing algorithms consider multiple genetic markers and clinical factors rather than relying on a single SNP.
Where can I find more information about pharmacogenomics?
You can visit resources like PharmGKB or MedlinePlus Genetics for reliable, evidence-based information on how genes affect drug response. These sites provide educational summaries on the current state of pharmacogenomic research.
Sources & further reading
Educational information only, last refreshed 11/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7294?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in VKORC1
The VKORC1 -1639G>A promoter variant reduces vitamin K epoxide reductase subunit 1 expression, requiring lower therapeutic warfarin maintenance doses to prevent bleeding complications.
This VKORC1 variant is a clinically useful marker for sensitivity to warfarin and related vitamin-K-antagonist dosing, with direct implications for medication safety.
Promoter variant in VKORC1 influencing warfarin sensitivity and dosing requirements.
Regulatory variant in the VKORC1 promoter region that significantly influences warfarin dose requirements.
Located in VKORC1, this missense variant (p.Val66Met) is associated with warfarin resistance requiring elevated therapeutic dosages.
Intronic regulatory variant in VKORC1 in high linkage disequilibrium with rs9923231, dictating clinical warfarin dosing requirements.